(Q44589859)

English

Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

10.1016/S0278-5846(03)00156-8

https://api.crossref.org/works/10.1016/S0278-5846(03)00156-8

11 March 2024

author name string

Oscar Gershanik

1

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Murat Emre

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Gudrun Bernhard

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dirk Sauer

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14499313

11 March 2024

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0278584603001568?httpAccept=text/xml

1 reference

10.1016/S0278-5846(03)00156-8

https://api.crossref.org/works/10.1016/S0278-5846(03)00156-8

11 March 2024

https://api.elsevier.com/content/article/PII:S0278584603001568?httpAccept=text/plain

1 reference

10.1016/S0278-5846(03)00156-8

https://api.crossref.org/works/10.1016/S0278-5846(03)00156-8

11 March 2024

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

963-971

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Levodopa: why the controversy?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: a randomised, placebo controlled, double blind, six month study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's disease and end-of-dose deterioration in daily medical practice: an open, multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Capturing the unexpected benefits of medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Twelve-month safety of entacapone in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of peripheral catechol-O-methyltransferase inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study).

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations. Nomecomt Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluating drug treatments for Parkinson's disease: how good are the trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of long-duration response to levodopa over time in PD: implications for wearing-off

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900156-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease

6

1 reference

10.1016/S0278-5846(03)00156-8

https://api.crossref.org/works/10.1016/S0278-5846(03)00156-8

11 March 2024

Identifiers

10.1016/S0278-5846(03)00156-8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44589859&oldid=2099669408"